Clinical Trial Update: Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis

View source ↗

Summary

A completed clinical trial evaluating nuclear magnetic spectroscopy imaging for Primary Lateral Sclerosis, Hereditary Spastic Paraplegia, and Amyotrophic Latera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Hereditary Spastic Paraplegia
• Lateral Sclerosis

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Primary Lateral Sclerosis, Hereditary Spastic Paraplegia | Status: COMPLETED